Clinical Trial Search

Primary: Oswestry Disability Index Questionnaire(ODI) for Lower Back Pain — 20.45; 19.02 Score on 0-100% scale

Primary: Number of Participants With One or More Treatment Emergent Adverse Events (TEAEs) and Serious Adverse Event(s) (SAEs) — 10; 10; 3; 0 participants

Primary: Number of Participants Who Experienced One or More Treatment-emergent Adverse Events (TEAEs) — 40 Participants

Primary: Recruitment — 20 Participants

Primary: Percentage of Wounds Healed Within 14 Days — 83.7; 74.8; 70.6 percentage of wounds healed

Primary: Proportion of Patients With Erectile Dysfunction Induced by Medical and Surgical Treatment of Rectal Cancer — 0 Participants

Primary: Determination of the Ratio of Sodium to Potassium (Na/K) in Urine — 1.12929; 0.98207; 1.04238; 0.54902 log10(10*Na/K)

Primary: Proportion of Patients Being Receiving Treatment Administration After Diagnosis — 372 Participants

Primary: Self-reported Receipt of COVID Vaccine Dose by 4 Weeks Post-intervention — 4; 7; 6; 462 Participants

Primary: Change From Baseline in Depressive Symptoms on Beck Depression Inventory-II (BDI-II) at Week 13 — 30.27; 29.62; 24.96; 23.98 units on a scale — p=0.862

Primary: Percentage of Participants With Gene Alterations inTissue Detected by NGS — 139; 106; 47 Participants

Primary: Ocular Itching as Measured by Self-reported Numerical Scales — -0.228; 0.010; -0.424; -0.035 score on a scale

Primary: Number of Participants With Unacceptable Toxicity. — 0 Participants

Primary: Doxycycline Concentrations in Rectal Tissues — 0.863; 2.193 µg/g

Primary: Favorable Clinical Outcomes (FCl) — 170; 132 Participants